From owner-chemistry@ccl.net Fri May  6 17:46:00 2022
From: "Abe Wang awang###collaborativedrug.com" <owner-chemistry,,server.ccl.net>
To: CCL
Subject: CCL: Live Webinar: COVID Moonshot - Collaborative Antiviral Discovery
Message-Id: <-54662-220506174428-22354-OjX3q0MdmCA5hyvQBk7nPw,,server.ccl.net>
X-Original-From: "Abe  Wang" <awang]_[collaborativedrug.com>
Date: Fri, 6 May 2022 17:44:25 -0400


Sent to CCL by: "Abe  Wang" [awang~~collaborativedrug.com]
COVID Moonshot - A Collaborative Approach to Antiviral Discovery
Thursday, June 9 at 9:00 am PT, 12:00 pm ET and 17:00 BST

In the early days of the COVID-19 pandemic, a group of scientists hailing from 
academic and industrial organizations around the world came together with the 
ambitious goal of discovering an antiviral against the virus. Two years later, 
the COVID Moonshot consortium has identified multiple compounds to be entered 
into preclinical trial.

Join this webinar to hear behind-the-scene stories of COVID Moonshot and learn 
how this non-profit, open-science project was able to achieve significant 
results with limited resources.

Speakers: Monalisa Chatterji, PhD (Sekkei Bio Pvt. Ltd.), Ed Griffen, PhD 
(MedChemica Ltd.) and Annette von Delft, MD, PhD (University of Oxford)


Free registration:
https://info.collaborativedrug.com/2022-q2-scientific-webinar